SC Filed 2022-11-21 Event — SEC 0001104659-22-120818 →

Hecht Peter M → Cyclerion Therapeutics, Inc. CYCN

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-08-31

DTC 1.00

18,067 shares short · -65.5% vs prior

Other 13D/G Filings on Cyclerion Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-18	SCHEDULE 13G	GENERAL ATLANTIC, L.P.	—	—	view →
2026-09-16	SCHEDULE 13G	Wellington Biomedical Innovation Master Investors (Cayman) II L.P.	—	—	view →
2026-09-15	SCHEDULE 13D	Venrock Healthcare Capital Partners III, L.P.	9.90%	4,552,277	view →
2026-09-11	SCHEDULE 13D	Fairmount Funds Management LLC	19.99%	9,103,729	view →
2026-08-14	SCHEDULE 13G	ADAR1 Capital Management, LLC	—	—	view →
2026-07-20	SCHEDULE 13D/A	Hecht Peter M	—	910,240	view →
2023-05-23	SC	Hecht Peter M	—	—	view →
2023-05-12	SC	Hecht Peter M	—	—	view →
2023-04-03	SC	Hecht Peter M	—	—	view →
2021-06-07	SC	Hecht Peter M	—	—	view →

Other Filings by Hecht Peter M

Filed	Form	Issuer	Stake	Shares
2026-07-20	SCHEDULE 13D/A	CYCLERION THERAPEUTICS, INC.	—	910,240	view →
2023-05-23	SC	Cyclerion Therapeutics, Inc. CYCN	—	—	view →
2023-05-12	SC	Cyclerion Therapeutics, Inc. CYCN	—	—	view →
2023-04-03	SC	Cyclerion Therapeutics, Inc. CYCN	—	—	view →
2021-06-07	SC	Cyclerion Therapeutics, Inc. CYCN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →